Medicines for influenza
Pro Research Analysisby 
Searched over 200M research papers
Medicines for Influenza: A Comprehensive Overview
Antiviral Drugs for Influenza Treatment
Neuraminidase Inhibitors: Oseltamivir and Zanamivir
Neuraminidase inhibitors, such as oseltamivir and zanamivir, are commonly used antiviral drugs for treating influenza. These drugs work by blocking the neuraminidase enzyme, which is essential for the virus to spread within the body. Oseltamivir has shown efficacy in reducing the duration of symptoms when administered within 48 hours of symptom onset, with a hazard ratio for time to alleviation of symptoms of 1.30 . However, it can cause side effects such as nausea, especially at higher doses . Zanamivir, administered via inhalation, has similar efficacy and safety profiles .
Amantadine and Rimantadine
Amantadine and rimantadine are older antiviral drugs that target the M2 protein of the influenza A virus. While amantadine can prevent 61% of influenza A cases, it is associated with significant side effects, including nausea, insomnia, and hallucinations . Due to these adverse effects and the development of resistance, the use of amantadine and rimantadine is generally discouraged .
Baloxavir Marboxil
Baloxavir marboxil is a newer antiviral drug that inhibits the cap-dependent endonuclease activity of the influenza virus, thereby preventing viral replication. It has shown a similar safety and efficacy profile to neuraminidase inhibitors and is a promising addition to the arsenal against influenza Świerczyńska2022Principi2019. Further research on combination therapies involving baloxavir marboxil is recommended to enhance its therapeutic potential .
Herbal Medicines for Influenza
Mao-to
Mao-to, a traditional Japanese herbal medicine, has been studied for its antipyretic effects in children with type A influenza. In a controlled trial, Mao-to significantly reduced the duration of fever compared to oseltamivir alone, demonstrating its potential as an effective treatment option .
Chinese Patent Medicines
Chinese patent medicines, such as Lianhua Qingwen capsules and Jinhua Qinggan granules, are widely used in China for treating influenza. These medicines have shown efficacy in reducing symptoms and improving recovery times, especially when combined with conventional antiviral treatments like oseltamivir Wu2020Li2022. A systematic review and meta-analysis indicated that combining Chinese patent medicines with oseltamivir significantly improved the time to symptom resolution and reduced hospitalization duration .
Systematic Reviews and Meta-Analyses
A comprehensive review of herbal medicines for influenza found that these treatments could significantly reduce the time to fever resolution and improve overall effectiveness compared to placebo . When combined with oseltamivir, herbal medicines further enhanced therapeutic outcomes without increasing adverse events .
Homeopathic Treatments
Oscillococcinum
Oscillococcinum, a homeopathic remedy, has been evaluated for its efficacy in preventing and treating influenza. However, the evidence remains inconclusive due to the low quality of the studies. While some trials reported a modest reduction in symptom duration, the overall effectiveness of Oscillococcinum is not well-supported by robust clinical data .
Combination Therapies
Antiviral Combinations
Combining antiviral drugs with different mechanisms of action is a promising strategy to enhance treatment efficacy and prevent resistance. Observational data suggest that combination therapies can reduce the progression to severe illness, especially in cases involving novel influenza strains . Early-stage studies highlight several promising antiviral combinations, but further clinical trials are needed to confirm their benefits .
Conclusion
The treatment of influenza involves a variety of antiviral drugs, herbal medicines, and combination therapies. Neuraminidase inhibitors like oseltamivir and zanamivir remain the mainstay of treatment, while newer drugs like baloxavir marboxil offer additional options. Herbal medicines, particularly when combined with conventional antivirals, show promise in improving treatment outcomes. However, the efficacy of homeopathic treatments like Oscillococcinum remains uncertain. Ongoing research and well-designed clinical trials are essential to optimize influenza treatment strategies and improve patient outcomes.
Sources and full results
Most relevant research papers on this topic